SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-008996
Filing Date
2018-11-08
Accepted
2018-11-08 16:02:35
Documents
84
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nviv-20180930x10q.htm 10-Q 1571118
2 EX-31.1 nviv-20180930ex3113fc7f3.htm EX-31.1 15125
3 EX-31.2 nviv-20180930ex31277f25b.htm EX-31.2 14657
4 EX-32.1 nviv-20180930ex321b806e2.htm EX-32.1 8164
5 EX-32.2 nviv-20180930ex32200698a.htm EX-32.2 8055
  Complete submission text file 0001558370-18-008996.txt   6650622

Data Files

Seq Description Document Type Size
6 EX-101.INS nviv-20180930.xml EX-101.INS 1201275
7 EX-101.SCH nviv-20180930.xsd EX-101.SCH 52239
8 EX-101.CAL nviv-20180930_cal.xml EX-101.CAL 43833
9 EX-101.DEF nviv-20180930_def.xml EX-101.DEF 253503
10 EX-101.LAB nviv-20180930_lab.xml EX-101.LAB 498820
11 EX-101.PRE nviv-20180930_pre.xml EX-101.PRE 438871
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37350 | Film No.: 181169607
SIC: 3841 Surgical & Medical Instruments & Apparatus